CN109576240A - A kind of amylosucrase mutant and the preparation method and application thereof - Google Patents

A kind of amylosucrase mutant and the preparation method and application thereof Download PDF

Info

Publication number
CN109576240A
CN109576240A CN201811547297.8A CN201811547297A CN109576240A CN 109576240 A CN109576240 A CN 109576240A CN 201811547297 A CN201811547297 A CN 201811547297A CN 109576240 A CN109576240 A CN 109576240A
Authority
CN
China
Prior art keywords
leu
mutant
amylosucrase
ala
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811547297.8A
Other languages
Chinese (zh)
Other versions
CN109576240B (en
Inventor
吴敬
吴丹
宿玲恰
赵雅琪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN201811547297.8A priority Critical patent/CN109576240B/en
Publication of CN109576240A publication Critical patent/CN109576240A/en
Application granted granted Critical
Publication of CN109576240B publication Critical patent/CN109576240B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/12—Disaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01004—Amylosucrase (2.4.1.4)

Abstract

The invention discloses a kind of amylosucrase mutant and the preparation method and application thereof, belong to genetic engineering and enzyme engineering field.The present invention will be serine from sucrose starches enzyme the 399th glycine mutation of Deinococcus Geothermalis, and gained amylosucrase mutant is applied to the production of turanose.The amylosucrase mutant is 35 DEG C in temperature, and initial pH has obtained turanose yield under conditions of being 7.0 reaches 32%, is 2 times of wild enzyme production turanose conversion ratio.Therefore, amylosucrase mutant of the invention can be applied in the preparation of turanose, and the conversion ratio of turanose is made to be further improved.

Description

A kind of amylosucrase mutant and the preparation method and application thereof
Technical field
The present invention relates to a kind of amylosucrase mutant and the preparation method and application thereof, belong to genetic engineering and enzyme engineering Field.
Background technique
Turanose is to be formed by a molecule glucose and a molecule fructose with α -1,3 glucosides key connections, is used as sucrose A kind of isomer, sugariness is only the half of sucrose.It has be easy crystallization, high soluble, hydrolysis rate is slow, be easy to and Other substances reconcile, not by cariogenic microbial fermentation the features such as, be suitable for suffer from obesity, hyperlipidemia, hypertension, diabetes et al. Group is edible.Therefore, turanose has the potentiality for becoming a new generation's functional sweetener low in calories in field of food.In addition, Turanose is also widely used in field of medicaments, can be used as the inhibitor of acid alpha-D-glucosidase, the medical treatment for Pang Beishi disease Diagnosis；Also there is antiinflammation, the inflammatory reaction etc. that lipopolysaccharides and glucose can be inhibited to mediate is a kind of with high added value Product.
At present enzyme process prepare the report of turanose only there are two types of.A kind of method is to be with the mixture of alpha-cyclodextrin and fructose Substrate synthesizes turanose using cyclodextrin glycosyltransferase, and the reachable maximum output of gained turanose is 45%.But the method The higher cost of the substrate utilized and the processing that need to separately be saccharified.Another method is to utilize amylosucrase using sucrose as substrate Sucrose isomerase is directly turned into turanose, cost is relatively low, technique is more succinct for the method substrate.
Amylosucrase belongs to alpha-amylase family (GH13), using sucrose as natural substrate, major catalytic polymerization and isomery This two big glycosides that turns reacts, and this two generation for turning glycosides reaction greatly depends on initial sucrose concentration.The starch when sucrose concentration is higher Based on invertase can be reacted with catalytic isomerization, primary product is turanose；When sucrose concentration is lower, amylosucrase then can be with Based on catalytic polymerization, generate largely with insoluble α-Isosorbide-5-Nitrae glycosidic linkage and with soluble malto-oligosaccharide.Cause This, in the preparation process of turanose, although polymerization reaction can be inhibited to a certain extent by the sucrose of high concentration, reaction When reducing to sucrose concentration, the generation of polymerization reaction still will affect the yield of final product.Therefore, a kind of polymerization activity is obtained The amylosucrase mutant of decrease has important commercial application potentiality for the conversion ratio for improving turanose.
Summary of the invention
A technical problem to be solved by this invention is to provide a kind of starch sugarcane that isoversion respond is promoted The mutant of carbohydrase.
The present invention pass through will set out amino acid sequence be SEQ ID NO.1 the 399th amino acids of amylosucrase by sweet Histidine mutations are serine, obtained amylosucrase mutant, have higher turanose transformation efficiency compared with parent.
In one embodiment of the invention, the source of the amylosucrase is moderate Thermophilic Bacteria (Deinococcus Geothermalis)。
In one embodiment of the invention, the amino acid sequence of the amylosucrase mutant such as SEQ ID Shown in NO.2.
Another technical problem to be solved by this invention is to provide a kind of method for preparing amylosucrase mutant, packet Include following steps:
(1) mutational site is determined on the basis of amylosucrase amino acid sequence；The mutant primer of rite-directed mutagenesis is designed, Carrier to carry amylosucrase gene carries out rite-directed mutagenesis as template；Construct the plasmid vector containing mutant；
(2) mutant plasmid is transformed into host cell；
(3) it selects positive colony and carries out fermented and cultured, prepare enzyme solution.
In one embodiment of the invention, the amino acid sequence such as SEQ ID NO.1 that sets out of the amylosucrase It is described.
In one embodiment of the invention, the source of the amylosucrase is moderate Thermophilic Bacteria (Deinococcus Geothermalis)。
In one embodiment of the invention, the amino acid sequence of the amylosucrase mutant such as SEQ ID Shown in NO.2.
In one embodiment of the invention, the plasmid vector be pUC series, pET series or pGEX in it is any It is a kind of.
In one embodiment of the invention, the host cell is bacterium or fungal cell.
In one embodiment of the invention, the bacterium is Gram-negative bacteria or gram-positive bacteria.
Another technical problem to be solved by this invention is to provide a kind of method for preparing turanose, the method be with Sucrose is substrate, is converted using sucrose starches enzyme mutant as catalyst；The sucrose enzyme mutant is by the ammonia that will set out The 399th amino acids of amylosucrase that base acid sequence is SEQ ID NO.1 are what serine obtained by glycine mutation.
In one embodiment of the invention, the conversion is 45~50h of progress under conditions of 30~40 DEG C.
Application of the amylosucrase mutant in terms of preparing the product containing turanose.
The utility model has the advantages that
The present invention constructs a kind of amylosucrase mutant and the preparation method and application thereof, amylosucrase mutant It is silk that G399S, which is by that will derive from the 399th glycine mutation of the amylosucrase of Deinococcus Geothermalis, What propylhomoserin obtained.Amylosucrase mutant G399S is applied to the production of turanose, at 35 DEG C, pine two under conditions of pH7.0 The conversion ratio of sugar is 2 times of wild enzymatic conversion rate up to 32.2%.Therefore, amylosucrase mutant of the invention can answer For making the conversion ratio of turanose be further improved in the preparation of turanose.
Detailed description of the invention
Fig. 1: the HPLC of turanose detects figure in amylosucrase mutant G399S transformation system.
Specific embodiment
LB solid medium: tryptone 10gL-1, yeast powder 5gL-1, sodium chloride 10gL-1, agar powder 20g L-1。
LB liquid medium: tryptone 10gL-1, yeast powder 5gL-1, sodium chloride 10gL-1。
TB culture medium: tryptone 12gL-1, yeast powder 24gL-1, glycerol 5gL-1, KH2PO42.31g·L-1, K2HPO4·3H2O 16.43g·L-1。
PBS buffer solution: sodium chloride 8.18gL-1, potassium chloride 0.2gL-1, disodium hydrogen phosphate 1.42gL-1, di(2-ethylhexyl)phosphate Hydrogen potassium 0.25gL-1, pH is adjusted to 7.4 with 2mol/L hydrochloric acid.
The calculation formula of turanose conversion ratio: (quality of turanose/initial sucrose quality) × 100%
The enzyme activity determination method of amylosucrase: using the side of 3,5- dinitrosalicylic acid system (DNS) and reduced sugar colour developing Method measures enzyme activity.With 50mM pH 7.0Tris-HCl buffer 0.3M sucrose solution, 1.9mL is added in tool plug test tube Substrate is added 0.1mL enzyme solution after 35 DEG C of water-baths preheat 10min, shakes and mix, 3mL DNS is added after reaction 30min and terminates instead It answers, then boil 7min and is cooled down with ice water rapidly, 10mL distilled water is finally added into above-mentioned reaction system, and in 540nm Lower measurement light absorption value.
The enzyme activity of amylosucrase defines: enzyme amount needed for catalysis generation per minute is equivalent to 1 μm of ol fructose is a work Unit of force.
Embodiment 1: recombinant bacterium building
According to the amino acid sequence (PDB ID:3UER) of amylosucrase dgas on NCBI, synthesized using chemical synthesis The dgas gene of amylosucrase.Plasmid for constructing Escherichia coli is pET24a (+), has T7 promoter.By pET24a (+) plasmid and dgas gene use Nde I and Hind III double digestion respectively, after digestion products are tapped and recovered, then with T4 ligase Connection, connection product Transformed E .coli JM109 competent cell obtain recombinant cell.Recombinant cell is cultivated through 37 DEG C of cultures 8h chooses transformant shake culture in LB liquid medium (card containing 30mg/L receive mycin), extracts plasmid, obtain after digestion verification Expression plasmid dgas/pET24a (+).
By plasmid dgas/pET24a (+) Transformed E .coli BL21 (DE3) host strain, it is coated with LB plate (card containing 30mg/L Receive mycin), 37 DEG C of culture 8h, obtained recombinant bacterium is named as E.coli J BL21 (DE3)/dgas/pET24a (+).Choose single bacterium It falls in LB liquid medium (card containing 30mg/L receive mycin), 37 DEG C of overnight incubations are stored in glycerol tube.
Embodiment 2: the preparation of single mutant
According to the dgas gene order for the amylosucrase that chemical synthesis in embodiment 1 synthesizes, introducing is designed and synthesized The primer of G399S mutation carries out rite-directed mutagenesis to amylosucrase dgas gene, measures DNA encoding sequence, identify the 399th The Gly codon of position becomes Ser codon.To carry the vector introduction bacillus subtilis of mutant gene, Escherichia coli or It is expressed in bacillus pumilus, obtains single mutation amylosucrase.
The rite-directed mutagenesis of G399S: utilizing fast PCR technology, is carried with carrying the expression of gene of wild type starch invertase Body dgas/pET24a (+) is template.
Introduce the rite-directed mutagenesis primer of G399S mutation are as follows:
Nucleotides sequence is classified as the forward primer of SEQ ID NO.3:
5’-GTCATGATGATATTAGCTGGGCAATTAGCG-3 ' (underscore is mutating alkali yl)
Nucleotides sequence is classified as the reverse primer of SEQ ID NO.4:
5’-CGCTAATTGCCCAGCTAATATCATCATGAC-3 ' (underscore is mutating alkali yl)
PCR reaction system is equal are as follows: 5 × PS buffer 10 μ L, dNTPs Mix (2.5mM) 4 μ L, forward primer (10 μM) 1 Distilled water is added to 50 μ L in μ L, 1 μ L of reverse primer (10 μM), template DNA 1 μ L, PrimerStar HS (5U/ μ L) 0.5 μ L.
PCR amplification condition are as follows: 94 DEG C of initial denaturation 4min；Subsequent 20 circulations (98 DEG C of 10s, 55 DEG C of 30s, 72 DEG C of 8min)； 72 DEG C are continued to extend 10min.
PCR product is digested through Dpn I, converts e. coli jm109 competence, and competent cell (contains in LB solid medium 30 μ g/mL cards receive mycin) after overnight incubation, chooses to be cloned in LB liquid medium (receiving mycin containing 30 μ g/mL cards) and mentioned after culture Plasmid is taken, all mutant plasmids are sequenced correctly, and obtained recombinant bacterium is named as E.coli JM109/dgas/pET24a (+) (G399S)。
Correct mutant is sequenced, is seeded to LB culture medium from glycerol tube, is incubated overnight, extracts plasmid, plasmid is converted Expressive host e. coli bl21 (DE3) competent cell, mutant plasmid are sequenced correctly, and obtained recombinant bacterium is named as E.coli J BL21(DE3)/dgas/pET24a(+)(G399S)。
Embodiment 3: the fermentation of amylosucrase mutant
Picking recombinant bacterium E.coli J BL21 (DE3)/dgas/pET24a (+) (G399S) (contains 30 in LB liquid medium μ g/mL card receives mycin) 8~10h of growth, seed fermentation liquid is connected to TB culture medium by 5% inoculum concentration and (is received containing 30 μ g/mL cards mould Element) in, 37 DEG C of shaking table culture OD600To after 0.2,0.4mM isopropyl ss-D-1- Thiogalactopyranoside (IPTG) is added and carries out Induction after fermenting for 24 hours at 25 DEG C, fermentation liquid is discarded supernatant in 4 DEG C, 8000rpm centrifugation 10min, collection thallus to 30OD, And redissolve laggard horizontal high voltage with the PBS buffer solution of pH7.4 and be homogenized broken wall, supernatant, which is collected, after 8000rpm centrifugation 10min is dashed forward Variant crude enzyme liquid.
Using same method, with recombinant bacterium E.coli J BL21 (DE3)/dgas/pET24a (+) fermentation in embodiment 1 Obtained broken wall enzyme solution is wild enzyme crude enzyme liquid.
Gained mutant crude enzyme liquid and wild enzyme crude enzyme liquid are subjected to enzyme activity determination respectively.The result shows that the enzyme of mutant Living is 1.5U/mL, and the enzyme activity of wild enzyme is 2.2U/mL.
The yield of embodiment 4:HPLC detection turanose
Mutant crude enzyme liquid or open country in the reactor of 10mL, after the broken wall obtained in 2g sucrose and 2mL example 3 is added Raw enzyme crude enzyme liquid is reacted 48 hours in 150rpm shaking bath, after reaction, is boiled under conditions of 35 DEG C, initial pH7.0 Boiling 10min inactivates enzyme, and 12000rpm is centrifuged 10min, collects supernatant, is diluted to 4 times with 50% (v/v) acetonitrile solution, finally It is filtered with 0.22 μm of filter.Gained filtrate measures the content of turanose, product absorption peak as sample by HPLC chromatogram As shown in Figure 1.
The condition of HPLC chromatogram analysis detection are as follows: Agilent 1200HPLC chromatograph, Agilent Composition distribution, color 5 μm of Syncronis Amino Column of column 4.6mm × 250mm are composed, mobile phase is the acetonitrile solution of 80% (v/v), flow velocity 0.8mL/min, 35 DEG C of column temperature.
It the results are shown in Table 1, it is the 2 of wild enzymatic conversion rate that the conversion ratio that single mutant G399S produces turanose, which is 32.2%, Times.
The conversion ratio of the wild enzyme of table 1 and mutant production turanose
Enzyme Produce the conversion ratio % of turanose
Wild enzyme 15.8
G399S 32.2
Although the present invention has been described by way of example and in terms of the preferred embodiments, it is not intended to limit the invention, any to be familiar with this skill The people of art can do various change and modification, therefore protection model of the invention without departing from the spirit and scope of the present invention Enclosing subject to the definition of the claims.
SEQUENCE LISTING
<110>Southern Yangtze University
<120>a kind of amylosucrase mutant and the preparation method and application thereof
<160> 4
<170> PatentIn version 3.3
<210> 1
<211> 650
<212> PRT
<213> Deinococcus Geothermalis
<400> 1
Met Leu Lys Asp Val Leu Thr Ser Glu Leu Ala Ala Gln Val Arg Asp
1 5 10 15
Ala Phe Asp Asp Asp Arg Asp Ala Glu Thr Phe Leu Leu Arg Leu Glu
20 25 30
Arg Tyr Gly Glu Asp Leu Trp Glu Ser Leu Arg Ala Val Tyr Gly Asp
35 40 45
Gln Val Arg Ala Leu Pro Gly Arg Leu Leu Glu Val Met Leu His Ala
50 55 60
Tyr His Ala Arg Pro Ala Glu Leu Arg Arg Leu Asp Glu Ala Arg Leu
65 70 75 80
Leu Arg Pro Asp Trp Leu Gln Arg Pro Glu Met Val Gly Tyr Val Ala
85 90 95
Tyr Thr Asp Arg Phe Ala Gly Thr Leu Lys Gly Val Glu Glu Arg Leu
100 105 110
Asp Tyr Leu Glu Gly Leu Gly Val Lys Tyr Leu His Leu Met Pro Leu
115 120 125
Leu Arg Pro Arg Glu Gly Glu Asn Asp Gly Gly Tyr Ala Val Gln Asp
130 135 140
Tyr Arg Ala Val Arg Pro Asp Leu Gly Thr Met Asp Asp Leu Ser Ala
145 150 155 160
Leu Ala Arg Ala Leu Arg Gly Arg Gly Ile Ser Leu Val Leu Asp Leu
165 170 175
Val Leu Asn His Val Ala Arg Glu His Ala Trp Ala Gln Lys Ala Arg
180 185 190
Ala Gly Asp Pro Lys Tyr Arg Ala Tyr Phe His Leu Phe Pro Asp Arg
195 200 205
Arg Gly Pro Asp Ala Phe Glu Ala Thr Leu Pro Glu Ile Phe Pro Asp
210 215 220
Phe Ala Pro Gly Asn Phe Ser Trp Asp Glu Glu Ile Gly Glu Gly Glu
225 230 235 240
Gly Gly Trp Val Trp Thr Thr Phe Asn Ser Tyr Gln Trp Asp Leu Asn
245 250 255
Trp Ala Asn Pro Asp Val Phe Leu Glu Phe Val Asp Ile Ile Leu Tyr
260 265 270
Leu Ala Asn Arg Gly Val Glu Val Phe Arg Leu Asp Ala Ile Ala Phe
275 280 285
Ile Trp Lys Arg Leu Gly Thr Asp Cys Gln Asn Gln Pro Glu Val His
290 295 300
His Leu Thr Arg Ala Leu Arg Ala Ala Ala Arg Ile Val Ala Pro Ala
305 310 315 320
Val Ala Phe Lys Ala Glu Ala Ile Val Ala Pro Ala Asp Leu Ile His
325 330 335
Tyr Leu Gly Thr Arg Ala His His Gly Lys Val Ser Asp Met Ala Tyr
340 345 350
His Asn Ser Leu Met Val Gln Leu Trp Ser Ser Leu Ala Ser Arg Asn
355 360 365
Thr Arg Leu Phe Glu Glu Ala Leu Arg Ala Phe Pro Pro Lys Pro Thr
370 375 380
Ser Thr Thr Trp Gly Leu Tyr Val Arg Cys His Asp Asp Ile Gly Trp
385 390 395 400
Ala Ile Ser Asp Glu Asp Ala Ala Arg Ala Gly Leu Asn Gly Ala Ala
405 410 415
His Arg His Phe Leu Ser Asp Phe Tyr Ser Gly Gln Phe Pro Gly Ser
420 425 430
Phe Ala Arg Gly Leu Val Phe Gln Tyr Asn Pro Val Asn Gly Asp Arg
435 440 445
Arg Ile Ser Gly Ser Ala Ala Ser Leu Ala Gly Leu Glu Ala Ala Leu
450 455 460
Glu Thr Gly Asp Pro Gly Arg Ile Glu Asp Ala Val Arg Arg Leu Leu
465 470 475 480
Leu Leu His Thr Val Ile Leu Gly Phe Gly Gly Val Pro Leu Leu Tyr
485 490 495
Met Gly Asp Glu Leu Ala Leu Leu Asn Asp Tyr Ala Phe Glu Asp Val
500 505 510
Pro Glu His Ala Pro Asp Asn Arg Trp Val His Arg Pro Gln Met Asp
515 520 525
Trp Ala Leu Ala Glu Arg Val Arg Gln Glu Pro Ser Ser Pro Ala Gly
530 535 540
Arg Val Asn Thr Gly Leu Arg His Leu Leu Arg Val Arg Arg Asp Thr
545 550 555 560
Pro Gln Leu His Ala Ser Ile Glu Ser Gln Val Leu Pro Ser Pro Asp
565 570 575
Ser Arg Ala Leu Leu Leu Arg Arg Asp His Pro Leu Gly Gly Met Val
580 585 590
Gln Val Tyr Asn Phe Ser Glu Glu Thr Val Met Leu Pro Ser His Val
595 600 605
Leu Arg Asp Val Leu Gly Asp His Val Gln Asp Arg Leu Ser Gly Ser
610 615 620
Ala Phe Arg Leu Asp Arg Pro Thr Val Arg Leu Glu Gly Tyr Arg Ala
625 630 635 640
Leu Trp Leu Thr Ala Gly Glu Ala Pro Ala
645 650
<210> 2
<211> 650
<212> PRT
<213>artificial synthesized
<400> 2
Met Leu Lys Asp Val Leu Thr Ser Glu Leu Ala Ala Gln Val Arg Asp
1 5 10 15
Ala Phe Asp Asp Asp Arg Asp Ala Glu Thr Phe Leu Leu Arg Leu Glu
20 25 30
Arg Tyr Gly Glu Asp Leu Trp Glu Ser Leu Arg Ala Val Tyr Gly Asp
35 40 45
Gln Val Arg Ala Leu Pro Gly Arg Leu Leu Glu Val Met Leu His Ala
50 55 60
Tyr His Ala Arg Pro Ala Glu Leu Arg Arg Leu Asp Glu Ala Arg Leu
65 70 75 80
Leu Arg Pro Asp Trp Leu Gln Arg Pro Glu Met Val Gly Tyr Val Ala
85 90 95
Tyr Thr Asp Arg Phe Ala Gly Thr Leu Lys Gly Val Glu Glu Arg Leu
100 105 110
Asp Tyr Leu Glu Gly Leu Gly Val Lys Tyr Leu His Leu Met Pro Leu
115 120 125
Leu Arg Pro Arg Glu Gly Glu Asn Asp Gly Gly Tyr Ala Val Gln Asp
130 135 140
Tyr Arg Ala Val Arg Pro Asp Leu Gly Thr Met Asp Asp Leu Ser Ala
145 150 155 160
Leu Ala Arg Ala Leu Arg Gly Arg Gly Ile Ser Leu Val Leu Asp Leu
165 170 175
Val Leu Asn His Val Ala Arg Glu His Ala Trp Ala Gln Lys Ala Arg
180 185 190
Ala Gly Asp Pro Lys Tyr Arg Ala Tyr Phe His Leu Phe Pro Asp Arg
195 200 205
Arg Gly Pro Asp Ala Phe Glu Ala Thr Leu Pro Glu Ile Phe Pro Asp
210 215 220
Phe Ala Pro Gly Asn Phe Ser Trp Asp Glu Glu Ile Gly Glu Gly Glu
225 230 235 240
Gly Gly Trp Val Trp Thr Thr Phe Asn Ser Tyr Gln Trp Asp Leu Asn
245 250 255
Trp Ala Asn Pro Asp Val Phe Leu Glu Phe Val Asp Ile Ile Leu Tyr
260 265 270
Leu Ala Asn Arg Gly Val Glu Val Phe Arg Leu Asp Ala Ile Ala Phe
275 280 285
Ile Trp Lys Arg Leu Gly Thr Asp Cys Gln Asn Gln Pro Glu Val His
290 295 300
His Leu Thr Arg Ala Leu Arg Ala Ala Ala Arg Ile Val Ala Pro Ala
305 310 315 320
Val Ala Phe Lys Ala Glu Ala Ile Val Ala Pro Ala Asp Leu Ile His
325 330 335
Tyr Leu Gly Thr Arg Ala His His Gly Lys Val Ser Asp Met Ala Tyr
340 345 350
His Asn Ser Leu Met Val Gln Leu Trp Ser Ser Leu Ala Ser Arg Asn
355 360 365
Thr Arg Leu Phe Glu Glu Ala Leu Arg Ala Phe Pro Pro Lys Pro Thr
370 375 380
Ser Thr Thr Trp Gly Leu Tyr Val Arg Cys His Asp Asp Ile Ser Trp
385 390 395 400
Ala Ile Ser Asp Glu Asp Ala Ala Arg Ala Gly Leu Asn Gly Ala Ala
405 410 415
His Arg His Phe Leu Ser Asp Phe Tyr Ser Gly Gln Phe Pro Gly Ser
420 425 430
Phe Ala Arg Gly Leu Val Phe Gln Tyr Asn Pro Val Asn Gly Asp Arg
435 440 445
Arg Ile Ser Gly Ser Ala Ala Ser Leu Ala Gly Leu Glu Ala Ala Leu
450 455 460
Glu Thr Gly Asp Pro Gly Arg Ile Glu Asp Ala Val Arg Arg Leu Leu
465 470 475 480
Leu Leu His Thr Val Ile Leu Gly Phe Gly Gly Val Pro Leu Leu Tyr
485 490 495
Met Gly Asp Glu Leu Ala Leu Leu Asn Asp Tyr Ala Phe Glu Asp Val
500 505 510
Pro Glu His Ala Pro Asp Asn Arg Trp Val His Arg Pro Gln Met Asp
515 520 525
Trp Ala Leu Ala Glu Arg Val Arg Gln Glu Pro Ser Ser Pro Ala Gly
530 535 540
Arg Val Asn Thr Gly Leu Arg His Leu Leu Arg Val Arg Arg Asp Thr
545 550 555 560
Pro Gln Leu His Ala Ser Ile Glu Ser Gln Val Leu Pro Ser Pro Asp
565 570 575
Ser Arg Ala Leu Leu Leu Arg Arg Asp His Pro Leu Gly Gly Met Val
580 585 590
Gln Val Tyr Asn Phe Ser Glu Glu Thr Val Met Leu Pro Ser His Val
595 600 605
Leu Arg Asp Val Leu Gly Asp His Val Gln Asp Arg Leu Ser Gly Ser
610 615 620
Ala Phe Arg Leu Asp Arg Pro Thr Val Arg Leu Glu Gly Tyr Arg Ala
625 630 635 640
Leu Trp Leu Thr Ala Gly Glu Ala Pro Ala
645 650
<210> 3
<211> 30
<212> DNA
<213>artificial synthesized
<400> 3
gtcatgatga tattagctgg gcaattagcg 30
<210> 4
<211> 30
<212> DNA
<213>artificial synthesized
<400> 4
cgctaattgc ccagctaata tcatcatgac 30

Claims (10)

1. a kind of amylosucrase mutant, which is characterized in that it is SEQ that the enzyme mutant, which is by the amino acid sequence that will set out, What the 399th amino acids of the amylosucrase of ID NO.1 were mutated.
2. amylosucrase mutant according to claim 1, which is characterized in that the enzyme mutant is by that will set out Amino acid sequence is that the 399th amino acids of the amylosucrase of SEQ ID NO.1 by glycine mutation are what serine obtained, It is named as G399S.
3. amylosucrase mutant according to claim 1 or 2, which is characterized in that the source of the amylosucrase For Deinococcus Geothermalis.
4. encoding a kind of gene of any amylosucrase mutant of claim 1-3.
5. a kind of method for preparing any amylosucrase mutant of claim 1-3, which is characterized in that including walking as follows It is rapid:
(1) mutational site is determined on the basis of amylosucrase amino acid sequence；The mutant primer of rite-directed mutagenesis is designed, to take Carrier with amylosucrase gene is that template carries out rite-directed mutagenesis；Construct the plasmid vector containing mutant；
(2) mutant plasmid is transformed into host cell；
(3) it selects positive colony and carries out fermented and cultured, prepare enzyme solution, obtain amylosucrase mutant.
6. preparation method according to claim 5, which is characterized in that the plasmid vector is pUC series, and pET is serial, or Any one in pGEX；The host cell is bacterium or fungal cell；The bacterium is that Gram-negative bacteria or leather are blue Family name's positive bacteria.
7. a kind of method for producing turanose, which is characterized in that the method is to be appointed using sucrose as substrate with claim 1-3 A kind of amylosucrase mutant described in one is catalyst, is turanose by sucrose inversion.
8. the method according to the description of claim 7 is characterized in that the concentration of the sucrose is 180~220g/L, the starch The concentration of sucrose enzyme mutant is 0.2~0.5U/mL.
9. the method according to the description of claim 7 is characterized in that it is described conversion be under the conditions of 30~40 DEG C carry out 45~ 50h。
10. a kind of any amylosucrase mutant the answering in terms of preparing the product containing turanose of claim 1-3 With.
CN201811547297.8A 2018-12-18 2018-12-18 Amylosucrase mutant and preparation method and application thereof Active CN109576240B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811547297.8A CN109576240B (en) 2018-12-18 2018-12-18 Amylosucrase mutant and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811547297.8A CN109576240B (en) 2018-12-18 2018-12-18 Amylosucrase mutant and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN109576240A true CN109576240A (en) 2019-04-05
CN109576240B CN109576240B (en) 2020-08-04

Family

ID=65930666

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811547297.8A Active CN109576240B (en) 2018-12-18 2018-12-18 Amylosucrase mutant and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN109576240B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110747245A (en) * 2019-11-29 2020-02-04 江南大学 Method for preparing malt oligosaccharide syrup by using complex enzyme
CN114908072A (en) * 2022-03-10 2022-08-16 江苏省奥谷生物科技有限公司 Beta-amylase mutant and application thereof in maltose preparation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2100966A1 (en) * 2008-03-12 2009-09-16 Institut Pasteur Mutants of glycoside hydrolases and uses thereof for synthesizing complex oligosaccharides and disaccharide intermediates
CN102021156A (en) * 2010-10-14 2011-04-20 广西科学院 Mutant of cane sugar hydrolytic enzyme and application of mutant
CN103937733A (en) * 2014-03-18 2014-07-23 南京工业大学 Genetic engineering strain utilize sucrose to produce succinic acid from and method for production of succinic acid by fermenting the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2100966A1 (en) * 2008-03-12 2009-09-16 Institut Pasteur Mutants of glycoside hydrolases and uses thereof for synthesizing complex oligosaccharides and disaccharide intermediates
CN102021156A (en) * 2010-10-14 2011-04-20 广西科学院 Mutant of cane sugar hydrolytic enzyme and application of mutant
CN103937733A (en) * 2014-03-18 2014-07-23 南京工业大学 Genetic engineering strain utilize sucrose to produce succinic acid from and method for production of succinic acid by fermenting the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GUERIN等: "tructural Investigation of the Thermostability and Product Specificity of Amylosucrase from the Bacterium Deinococcus geothermalis", 《THE JOURNAL OF BIOLOGICAL CHEMISTRY》 *
赵雅琪: "松二糖的酶法制备研究", 《中国优秀硕士学位论文全文数据库（基础科学辑）》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110747245A (en) * 2019-11-29 2020-02-04 江南大学 Method for preparing malt oligosaccharide syrup by using complex enzyme
CN110747245B (en) * 2019-11-29 2021-07-27 江南大学 Method for preparing malt oligosaccharide syrup by using complex enzyme
CN114908072A (en) * 2022-03-10 2022-08-16 江苏省奥谷生物科技有限公司 Beta-amylase mutant and application thereof in maltose preparation

Also Published As

Publication number Publication date
CN109576240B (en) 2020-08-04

Similar Documents

Publication Publication Date Title
US10876099B2 (en) Preparation and application of cyclodextrin glucosyltransferase mutant
CN110592059B (en) Maltooligosyl trehalose synthase mutant
CN109486786A (en) A kind of yclodextrin glycosyltransferase mutant
CN112695021B (en) Alpha-glycosidase gene mutant and application thereof in preparation of 2-O-alpha-D-glucosyl-L-ascorbic acid
CN107446900B (en) A kind of trehalose synthase and its preparation method and application
CN108424868A (en) A kind of recombinant bacterium using natural double carbon source high yield N-acetyl-neuraminates
CN109402081A (en) A kind of amylosucrase mutant and the preparation method and application thereof
CN110055233B (en) MTSase mutant with improved thermal stability and application thereof
CN109576240A (en) A kind of amylosucrase mutant and the preparation method and application thereof
CN114480465A (en) Bacillus subtilis for producing 2&#39; -fucosyllactose and application thereof
CN113151198B (en) Gamma-glutamine synthetase mutant, coding gene, amino acid sequence and application thereof
CN110656096B (en) Cyclodextrin glucosyltransferase mutant for reducing hydrolysis side reaction degree
CN108753746B (en) Maltooligosyl trehalose synthase mutant with improved thermal stability
CN111172089A (en) Method for synthesizing trehalose by using recombinant trehalose synthase
CN109456950A (en) A kind of mutant of cyclodextrin glycosyltransferase and its application
CN113308446B (en) Maltooligosyl trehalose synthase mutant with improved trehalose conversion rate and application thereof
CN112410322B (en) Bacillus licheniformis beta-mannase mutant and application thereof
CN111534498B (en) Cyclodextrin glucosyltransferase mutant with improved disproportionation specific activity and AA-2G yield
CN108998431B (en) A method of improving 4- alpha-glycosyl transferase Soluble expression levels
CN109370973B (en) Maltogenic amylase producing strain
CN112980762A (en) Aspergillus niger disaccharide phosphorylase and application thereof in preparation of aspergillus niger disaccharide
CN109486793A (en) A kind of sucrose hydrolysis enzyme mutant and the preparation method and application thereof
CN113493747A (en) Mutant strain of high-yield cyclodextrin glucosyltransferase and application thereof
CN109468298A (en) A kind of amylosucrase mutant improving turanose yield
CN109439607A (en) A kind of application of maltogenic amylase production bacterial strain

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant